Ozempic for Weight Loss: Dosing, Results and What to Expect Ozempic has become one of the most talked-about medications for weight loss, even though the FDA didnt actually approve it for that purpose
The STEP trials (Semaglutide Treatment Effect in People with obesity) followed participants for 68 weeks of active treatment, showing sustained weight reduction without dose escalation
In this post-analysis of 327 participants, the average weight loss after 68 weeks was 17.3% with semaglutide and 2% with placebo
Frssing, S., Nylander, M., Kistorp, C., Faber, J., Christiansen, M., & Naver, L
EMSculpt NEO at Phelts Chiropractic 369 Lexington Avenue, Suite 214 New York, NY 10017